Quels malades peuvent et doivent aller en réanimation ?: Which patients can and should go to intensive care?
Advanced care planning
ICU trial
Intensive care unit
Organ dysfunction
lung neoplasm
Journal
Revue des maladies respiratoires actualites
ISSN: 1877-1203
Titre abrégé: Rev Malad Respir Actual
Pays: France
ID NLM: 101517384
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
ppublish
Résumé
When a lung cancer patient develops an organ failure, the intensity of the care should be decided taking into account patient's wishes and his plan of carekeeping, in mind that the objective of an intensive care unit (ICU) admission is to allow the patient to be discharged from ICU and hospital with an acceptable quality of life. But the physician in charge of the patient at the time of acute disease often does not have these information. It is therefore essential that the referring oncologist had an early discussion with the patient to inform him and collect his opinion. These information have to be noted in the patient's medical chart. The prognostic criteria of lung cancer patients admitted in ICU are related to the patient's characteristics, the cancer's characteristics and the severity of acute disease. In order that a decision of ICU admission is in accordance with the patient's therapeutic project, a close discussion between the oncologist and the intensivist is essential, especially in this period of SARS-CoV2 pandemy.© 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Identifiants
pubmed: 34659596
doi: 10.1016/S1877-1203(21)00116-6
pii: S1877-1203(21)00116-6
pmc: PMC8512108
doi:
Types de publication
English Abstract
Journal Article
Langues
fre
Pagination
2S244-2S251Informations de copyright
Copyright © 2021 SPLF. Publié par Elsevier Masson SAS. Tous droits réservés. Published by Elsevier Masson SAS All rights reserved.
Références
Intensive Care Med. 2021 Feb;47(2):170-179
pubmed: 32770267
Crit Care Med. 2017 Oct;45(10):1668-1676
pubmed: 28682838
Ann Oncol. 2020 Oct;31(10):1386-1396
pubmed: 32561401
Rev Med Suisse. 2019 May 1;15(649):924-928
pubmed: 31050240
Crit Care Med. 2010 Jan;38(1):9-15
pubmed: 19829101
Ann Intensive Care. 2018 Mar 27;8(1):40
pubmed: 29582210
J Clin Oncol. 2012 Dec 10;30(35):4387-95
pubmed: 23150700
JAMA Oncol. 2016 Jan;2(1):76-83
pubmed: 26469222
Eur Respir J. 2008 Jan;31(1):47-53
pubmed: 17715168
J Med Ethics. 2021 Jan 5;:
pubmed: 33402429
J Crit Care. 2020 Dec;60:267-272
pubmed: 32932112
J Palliat Med. 2017 Dec;20(12):1366-1371
pubmed: 28737996
J Thorac Dis. 2016 Nov;8(11):E1455-E1461
pubmed: 28066630
J Cancer Res Clin Oncol. 2018 Apr;144(4):717-723
pubmed: 29362918
Crit Care Med. 2017 Jul;45(7):e640-e648
pubmed: 28398925
JAMA. 2016 Jan 19;315(3):255-6
pubmed: 26784767
Ann Oncol. 2014 Sep;25(9):1829-1835
pubmed: 24950981
ESMO Open. 2020 Oct;5(5):e000950
pubmed: 33109628
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
Ann Hematol. 2018 Jul;97(7):1271-1282
pubmed: 29704018
Ann Transl Med. 2017 Dec;5(Suppl 4):S37
pubmed: 29302593
BMC Cancer. 2021 Jan 5;21(1):9
pubmed: 33402107
J Clin Oncol. 2011 Jun 20;29(18):2474-80
pubmed: 21576638
Support Care Cancer. 2020 Oct;28(10):5037-5044
pubmed: 32734394
Oncologist. 2017 Mar;22(3):318-323
pubmed: 28220023
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
JAMA Oncol. 2015 Nov;1(8):1078-85
pubmed: 26313462
Eur J Cancer. 2020 Dec;141:62-81
pubmed: 33129039
Intensive Care Med. 2015 Jan;41(1):164-5
pubmed: 25366122
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
J Palliat Med. 2018 May;21(5):689-693
pubmed: 29480751
BMC Cancer. 2011 May 02;11:159
pubmed: 21535895
Lancet Respir Med. 2019 Jul;7(7):613-625
pubmed: 31122895
BMJ. 2010 Mar 23;340:c1345
pubmed: 20332506
Ann Intensive Care. 2017 Dec;7(1):26
pubmed: 28265980
Ann Intensive Care. 2011 Mar 23;1(1):5
pubmed: 21906331
Lung Cancer. 2015 Aug;89(2):218-21
pubmed: 26022271
Cancers (Basel). 2021 Mar 21;13(6):
pubmed: 33801131
Lancet Oncol. 2020 Jul;21(7):914-922
pubmed: 32539942
JTO Clin Res Rep. 2021 Mar;2(3):100141
pubmed: 33437971
Intensive Care Med. 2012 Sep;38(9):1505-13
pubmed: 22592633
Eur Respir J. 2015 Feb;45(2):491-500
pubmed: 25323247
Crit Care Med. 2016 May;44(5):926-33
pubmed: 26765498
J Immunother Cancer. 2021 Mar;9(3):
pubmed: 33737345
JAMA. 2003 Aug 13;290(6):790-7
pubmed: 12915432
Lung Cancer. 2021 Jul;157:109-115
pubmed: 34016490
J Cancer. 2017 Jul 5;8(11):1995-2003
pubmed: 28819399
Clin Lung Cancer. 2016 Nov;17(6):523-527
pubmed: 27256487
Intensive Care Med. 2009 Dec;35(12):2044-50
pubmed: 19768453
Chest. 2011 Jan;139(1):101-8
pubmed: 20634283
Crit Care Med. 2020 Jan;48(1):10-21
pubmed: 31725440
Crit Care Med. 2016 Mar;44(3):548-53
pubmed: 26562345